Journal
JOURNAL OF NEUROIMMUNE PHARMACOLOGY
Volume 1, Issue 3, Pages 305-316Publisher
SPRINGER
DOI: 10.1007/s11481-006-9022-6
Keywords
Ca2+; G-protein coupled receptors; matrix metalloprotease; NO (nitric oxide); ONOO- (peroxynitrite); S-nitrosylation
Categories
Funding
- NIDA NIH HHS [U24 DA012385, U24-DA12385, R01 DA003690, R01-DA03690] Funding Source: Medline
- NIGMS NIH HHS [S06 GM08049] Funding Source: Medline
- NIMHD NIH HHS [P20-MD00175] Funding Source: Medline
- PHS HHS [K05-00182] Funding Source: Medline
Ask authors/readers for more resources
Neuropathologies that affect our population include ischemic stroke and neurodegenerative diseases of immune origin, including multiple sclerosis. The endocannabinoid system in the brain, including agonists anandamide (arachidonyl ethanolamide) and 2-arachidonoylglycerol, and the CB1 and CB2 cannabinoid receptors, has been implicated in the pathophysiology of these disease states, and can be a target for therapeutic interventions. This review concentrates on cellular signal transduction pathways believed to be involved in the cellular damage.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
